Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 35.83x is 644% above its 5-year average of 4.82x, near the low end of its 5-year range (-39.92x–7816.67x).
114.07% above its 12-month average of 16.74x.
Reported quarterly interest coverage; no daily interpolation. Q1 FY2026 (2026-03-31): -39.92x.
INTEREST COVERAGE RATIO
35.83x
INTEREST COVERAGE RATIO AVG TTM
16.74x
INTEREST COVERAGE RATIO AVG 3Y
15.86x
INTEREST COVERAGE RATIO AVG 5Y
4.82x
INTEREST COVERAGE RATIO AVG 10Y
8.06x
INTEREST COVERAGE RATIO AVG 15Y
-1.60x
INTEREST COVERAGE RATIO AVG 20Y
-3.20x
CURRENT VS TTM AVG
+114.07%
CURRENT VS 3Y AVG
+125.96%
CURRENT VS 5Y AVG
+643.57%
CURRENT VS 10Y AVG
+344.54%
CURRENT VS 15Y AVG
+2339.94%
CURRENT VS 20Y AVG
+1219.14%
SECTOR MEDIAN · HEALTHCARE
-5.64x
median of 457 covered companies
CURRENT VS SECTOR MEDIAN
+735.28%
vs the sector median at left
MiMedx Group, Inc.
Market Cap
$669.77M
Interest Coverage Ratio
35.83x
TTM Avg
16.74x
3Y Avg
15.86x
5Y Avg
4.82x
Market Cap
$670.70M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$680.31M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$689.73M
Interest Coverage Ratio
-1286.22x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$642.27M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$637.17M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MiMedx Group, Inc. (MDXG) | $669.77M | 35.83x | 16.74x | 15.86x | 4.82x |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $670.70M | N/A | N/A | N/A | N/A |
| Annexon, Inc. (ANNX)vs › | $677.49M | N/A | N/A | N/A | N/A |
| Helus Pharma Inc. (HELP)vs › | $680.31M | N/A | N/A | N/A | N/A |
| Anteris Technologies Global Corp. (AVR)vs › | $689.73M | -1286.22x | N/A | N/A | N/A |
| ArriVent BioPharma, Inc. (AVBP)vs › | $642.27M | N/A | N/A | N/A | N/A |
| Aura Biosciences, Inc. (AURA)vs › | $637.17M | N/A | N/A | N/A | N/A |
| OmniAb, Inc. (OABI)vs › | $648.75M | N/A | N/A | N/A | N/A |
| Climb Bio, Inc. (CLYM)vs › | $633.33M | N/A | N/A | N/A | N/A |
| Prime Medicine, Inc. (PRME)vs › | $633.97M | N/A | N/A | N/A | N/A |
Interest Coverage
35.8x
Debt/Equity
0.01
Current Ratio
5.33
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-03-31 | -39.92x |
| 2025-12-31 | 52.04x |
| 2025-09-30 | 28.27x |
| 2025-06-30 | 26.04x |
| 2025-03-31 | 17.26x |
| 2024-12-31 | 4.37x |
| 2024-06-30 | 7816.67x |
| 2024-03-31 | 7.81x |
| 2023-12-31 | 9.72x |
| 2023-09-30 | 6.62x |
| 2023-06-30 | 6.65x |
| 2023-03-31 | -0.22x |
| 2022-12-31 | 0.74x |
| 2022-09-30 | -5.59x |
| 2022-06-30 | -8.24x |
| 2022-03-31 | -8.26x |
| 2021-12-31 | 2.81x |
| 2021-09-30 | -1.12x |
| 2021-06-30 | -0.30x |
| 2021-03-31 | -4.65x |
| 2020-12-31 | -10.67x |
| 2020-09-30 | -6.59x |
| 2020-06-30 | -2.28x |
| 2020-03-31 | -5.76x |
| 2019-12-31 | -2.03x |
| 2019-09-30 | 6.30x |
| 2019-06-30 | -63.47x |
| 2017-09-30 | 205.63x |
| 2017-06-30 | 48.41x |
| 2016-12-31 | 102.53x |
| 2016-09-30 | 54.06x |
| 2016-06-30 | 32.08x |
| 2016-03-31 | 26.20x |
| 2015-12-31 | 113.99x |
| 2015-09-30 | 1342.80x |
| 2015-06-30 | 5652.00x |
| 2015-03-31 | 303.36x |
| 2014-12-31 | 493.79x |
| 2014-09-30 | 414.56x |
| 2014-06-30 | -46.51x |
| 2014-03-31 | -42.38x |
| 2013-12-31 | -110.92x |
| 2013-09-30 | -56.53x |
| 2013-06-30 | -56.50x |
| 2013-03-31 | -0.17x |
| 2012-12-31 | -1.14x |
| 2012-09-30 | -0.88x |
| 2012-06-30 | -0.19x |
| 2012-03-31 | -1.37x |
| 2011-12-31 | -17.24x |
| 2011-09-30 | -14.58x |
| 2011-06-30 | -27.75x |
| 2011-03-31 | -35.70x |
| 2010-12-31 | -8.27x |
| 2010-09-30 | -4886.74x |
| 2010-06-30 | -2196.90x |
| 2010-03-31 | -4.29x |
| 2009-09-30 | -1.73x |
| 2009-06-30 | -38.64x |
| 2007-12-31 | -11.01x |
| 2007-09-30 | -7.82x |
| 2007-06-30 | -17.93x |